Insights

Insights

Facility

Stelis Biopharma receives EU-GMP certification for two of its manufacturing facilities

Stelis Biopharma, the biologics arm of Strides Pharma Science announced that

no
Stelis Next Phase

COVID impact report 

January 2021 In 2020 the Coronavirus pandemic has, unsurprisingly, proved to

no
i-picked hack of a time

I Picked A Heck Of A Time

A new CEO’s observations on managing a fast-growing, fully integrated biophar

no
Unit 2 Bangalore

Stelis starts next phase of investment into its biologics manufacturing facility

This phase sees the CDMO start work on installing two 2,000-L single-use bior

no
south-bangalore-1

Unit 1 – Bangalore, India

State-of-the-art process and analytical development facilities for small-scal

no
north-bangalore

Unit 2 – Bangalore, India

Integrated state-of-the-art manufacturing facility leverages microbial and ma

no
Unit-3 Bangalore

Unit 3 – Bangalore, India

A multipurpose facility with an ability to cater to multiple vaccine types in

no
Outsourcing Formulation

Meeting Demand for Biologics & Specialty Drugs

A company that provides insurance and investment-related products and service

no
Overcoming Biologic

Overcoming Biologic Drug Formulation Hurdles

A company that provides insurance and investment-related products and service

no
Stelis Concludes

Stelis concludes US$ 195m Series B and Series C fund raise

Stelis Biopharma (Stelis) today announced that it has successfully concluded

no

Our Corporate Governance









    captcha









      captcha